CCR7 and cancer: The downregulation of let-7a-5p may be related to barrier abnormalities by targeting ribonucleotide reductase regulatory subunit M2 (RRM2) and C-C motif chemokine receptor 7 (CCR7) [95], which are mainly involved in cancer cell proliferation.